Scholars Central

EditorialPublished 9 Nov 2012

New Biomarkers Improving Cervical Cancer Screening Efficacy

Authors: Massimo Origoni

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Carcinoma of the uterine cervix is the third most commonly diagnosed malignant neoplasm in women and the second cancerrelated cause of deaths in many low-resources geographical areas. Cervical cancer cytological screening programs, since the introduction in clinical practice of the Papanicolaou vaginal smear– the Pap test – have represented one of the major public health advantages and improvements of the last century; where cervical cancer screening is realized, incidence and mortality due to this disease have demonstrated a dramatic reduction. Despite this observation, invasive cervical cancer still accounts for almost 500,000 new cases per year worldwide, with approximately 11,000 and 4,000 new cases and deaths respectively in the USA per year.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Womens Health, Issues and Care
  • SubjectReproductive Medicine & Gynaecology
  • BylineArticles whose byline prints “Massimo Origoni”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels